Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt

Saudi Pharmaceutical Journal

Volumn 18, Issue 4, 2010, Pages 225-232

  Shams, Mohamed E E ^a,c   Barakat, Enaase A M E ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c MINISTRY OF HEALTH   (Oman)

Author keywords

Drug compliance; Oral hypoglycemic agents; Pharmaceutical care; T2DM; Therapeutic adherence

Indexed keywords

BIGUANIDE; GLUCOSE; SULFONYLUREA;

ADULT; ADVERSE DRUG REACTION; ARTICLE; BLOOD GLUCOSE MONITORING; DIET THERAPY; DRUG COST; DRUG DOSE REGIMEN; EGYPT; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH BELIEF; HEALTH CARE COST; HUMAN; INCOME; INTERVIEW; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MOTIVATION; MULTIPLE CHOICE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; PATIENT COMPLIANCE; POLYPHARMACY; QUESTIONNAIRE; SELF MONITORING; SOCIAL STATUS; SOCIAL SUPPORT;

EID: 80051755865     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2010.07.004     Document Type: Article

References (51)

1. Adisa R., Alutundu M.B., Fakeye T.O. Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharm. Pract. (Internet) 2009, 7:163-169.
2. Al-Elq A.H. Current practice in the management of patients with type 2 diabetes mellitus in Saudi Arabia. Saudi Med. J. 2009, 30:1551-1556.
3. Arun K., Murugan R., Rajesh Kanna M., Rajalakshmi S., Kalaiselvi R., Komathi V. The impact of pharmaceutical care on the clinical outcome of diabetes mellitus among a rural patient population. Int. J. Diabetes Dev. Ctries. 2008, 28:15-18.
4. Bender B.G., Bender S.E. Patient-identified barriers to asthma treatment adherence. Responses to interviews, focus groups, and questionnaires. Immunol. Allergy Clin. North Am. 2005, 25:107-130.
5. Beziea Y., Molinaa M., Hernandezb N., Batistaa R., Nianga S., Huetb D. Therapeutic compliance. A prospective analysis of various factors involved in the adherence rate in type 2 diabetes. Diabetes Metab. 2006, 32:611-616.
6. Choi-Kwon S., Kwon S.U., Kim J.S. Compliance with risk factor modification: early-onset versus late-onset stroke patients. Eur. Neurol. 2005, 54:204-211.
7. Clark W.F., Forwell L. Patient compliance with drug therapy for diabetic nephropathy. Can. Med. Assoc. J. 2000, 162:1553-1560.
8. Cooper C., Carpenter I., Katona C. The AdHOC study of older adults' adherence to medication in 11 countries. Am. J. Geriatr. Psychiatry 2005, 13:1067-1076.
9. Cramer J., Roy A., Burrell A., Anuja R., Burrell A., Fairchild C., Fuldeore M., Ollendorf D., Wong P. Medication compliance and persistence. Terminology and definitions. Value Health 2008, 11:44-47.
10. Delgado A., Lima M. Contributo para a validação concorrente de uma medidade de adesão aos tratamentos. Psicologia, Saúde & Doenças 2001, 2:81-100.
11. Diabetes Atlas, second ed. International Diabetes Federation, Brussels, 2003.
12. Donnan P.T., MacDonald T.M., Morris A.D. Adherence of prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabetes Med. 2002, 19:279-284.
13. Gascon J.J., Sanchez-Ortuno M., Llor B. Treatment compliance in hypertension study group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004, 21:125-130.
14. Girerd X., Hanon O., Anagnostopoulos K., Ciupek C., Mourad J., Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Pressed Med. 2001, 30:1044-1048.
15. Harris M.I., Cowie C.C., Howie L.J. Self monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 1993, 16:1116-1123.
16. Hedtke P.A. Can wireless technology enable new diabetes management tools?. J. Diabetes Sci. Technol. 2008, 2:127-130.
17. Hensrud D.D. Dietary treatment and long-term weight loss and maintenance in type 2 diabetes. Obes. Res. 2001, 9:348-353.
18. Hertz R.P., Unger A.N., Lustik M.B. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employersponsored health insurance. Clin. Ther. 2005, 27:1064-1073.
19. Iskedjian M., Einarson T.R., MacKeigan L.D. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin. Ther. 2002, 24:302-316.
20. Jayant D., Lawrence B., Richard G. Factor influencing patient acceptability of diabetes treatment regimens. Clin. Diabetes 2000, l8:2-12.
21. Kalyango J., Owino E., Nambuya A. Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr. Health Sci. 2008, 8:67-73.
22. Kaplan R.C., Bhalodkar N.C., Brown E.J. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev. Med. 2004, 39:1249-1255.
23. Kasznicki J., Głowacka A., Drzewoski J. Type 2 diabetic patients compliance with drug therapy and glycaemic control. Diabetologia Doświadczalna i Kliniczna 2007, 7:199-203.
24. Khattab M.S., Abolotouh M.A., Khan M.Y., Humaidi M.A., Al-Khaldi Y.M. Compliance and control of diabetes in a family practice setting, Saudi Arabia. East Mediterr. Health J. 1999, 4:755-765.
25. Kurtz M.S. Adherence to diabetic regimens: empirical status and clinical applications. Diabetes Educ. 1990, 16:50-56.
26. Lawson V.L., Lyne P.A., Harvey J.N. Understanding why people with type 1 diabetes do not attend for specialist advice. A qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic. J. Health Psychol. 2005, 10:409-423.
27. Lertmaharit S., Kamol-Ratankul P., Sawert H. Factors associated with compliance among tuberculosis patients in Thailand. J. Med. Assoc. Thai. 2005, 88:149-156.
28. Liu H., Kaplan A.H., Wenger N.S. Measuring patient adherence. Ann. Intern. Med. 2002, 137:72-73.
29. Lopes N., Zanini A.C., Casella-Filho A., Chagas A.C.P. Metabolic syndrome patient compliance with drug treatment. Clinics 2008, 63:573-580.
30. Maddigan S.L., Feeny D.H., Johnson J.A. Health related quality of life deficits associated with diabetes and co morbidities in a Canadian national population health survey. Qual. Life Res. 2005, 14:1311-1320.
31. Martin L., Williams S., Haskard K., DiMatteo M.R. The challenge of patient adherence. Ther. Clin. Risk Manage. 2005, 1:189-199.
32. Mishra P., Hansen E.H., Sabroe S. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int. J. Tuberc. Lung Dis. 2005, 9:1134-1139.
33. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of self-reported measure of medication adherence. Med. Care 1986, 24:67-74.
34. Muszbek N., Brixner D., Benedict A., Keskinaslan A., Khan Z.M. The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int. J. Clin. Pract. 2008, 62:338-351.
35. Norell S.E. Memory and medication compliance. J. Clin. Hosp. Pharm. 1985, 10:107-109.
36. Odegard P., Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007, 33:1014-1029.
37. Ohene-Buabeng K., Motowel L., Plange-Rhule J. Unaffordable drug prices: the major cause of noncompliance with hypertensive medication in Ghana. J. Pharm. Sci. 2004, 7:350-352.
38. Osterberg L., Blaschke T. Adherence to medication. N. Engl. J. Med. 2005, 353:487-497.
39. Paulose K. Disease awareness study in diabetic patients. Asian J. Diabetes 2000, 2:15-19.
40. Ponnusankar S., Surulivelrajan M., Anandamoorthy N. Assessment of impact of medication counseling on patients' medication knowledge and compliance in an outpatient clinic in South India. Patient Educ. Couns. 2004, 54:55-60.
41. Rickles N., Brown T., McGivney M., Snyder M., White K. Adherence. A review of education, research, practice, and policy in the United States. J. Pharm. Pract. (Internet) 2010, 8:1-17.
42. Rudd P., Byyny R.L., Zachary V., LoVerde M.E., Mitchell W.D., Titus C., Marshall G. Pill count measures of compliance in a drug trial: variability and suitability. Am. J. Hypertens. 1998, 1:309-312.
43. Schectman-Joel M., Nadakarni-Mohan M., Voss-John D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002, 25:1015-1021.
44. Senior V., Marteau T.M., Weinman J. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovasc. Drugs Ther. 2004, 18:475-481.
45. Seol M.A., Min S.K. Development of a structural model explaining medication compliance of persons with schizophrenia. Yonsei Med J. 2005, 46:331-340.
46. Spikmans F.J., Brug J., Doven M.M. Why do diabetic patients not attend appointments with their dietitian?. J. Hum. Nutr. Diet 2003, 16:151-158.
47. Sweileh W., Aker O., Hamooz S. Effect of polypharmacy and frequency of drug dosing" on rate of compliance among diabetic and hypertensive patients: a survey study in Palestine. An-Najah Univ. J. 2003, 17:155-165.
48. Sweileh W., Aker O., Hamooz S. Rate of compliance among patients with diabetes mellitus and hypertension. An-Najah Univ. J. 2005, 19:2-11.
49. The World Health Report, 2003. Shaping the Future. World Health Organization, Geneva.
50. Vermeire, E., Wens, J., Van Royen, P., Biot, Y., Hearnshaw, H., Lindenmeyer, A., 2005. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst. Rev. 18, CD003638.
51. Voils C.I., Steffens D.C., Flint E.P. Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. Am. J. Geriatr. Psychiatry 2005, 13:157-165.